|BSE: 526345||Sector: Health care|
|NSE: N.A.||ISIN Code: INE744D01019|
|BSE 05:30 | 01 Jan||Panjon Ltd|
|NSE 05:30 | 01 Jan||Panjon Ltd|
Panjon Ltd. (PANJON) - News Sector
10.08 am | 23 Mar 2018 | Business Standard
BHEL, Ambuja Cements, Bharat Electronics, Cadila Healthcare, Cummins India, Indian Oil, Lupin and Power Finance Corporation were among 60 stocks from ...
11.54 pm | 22 Mar 2018 | Business Standard
Given pricing pressure in the US on its generic portfolio, Sun Pharma has been focusing on bringing to the market its next growth vehicle in the form ...
9.29 am | 22 Mar 2018 | Business Standard
The stock was trading 2% higher at Rs 515 as compared to a marginal 0.05% gain in the S&P BSE Sensex at 09:17 am.
1.54 am | 22 Mar 2018 | Business Standard
The stock was trading at 17 times its 2020 earnings estimates
8.22 pm | 21 Mar 2018 | Business Standard
The market for psoriasis drugs in US is over $ 6 billion and the approval allows the drugmaker to expand its portfolio in dermatology space
1.17 pm | 20 Mar 2018 | Business Standard
The stock moved higher to Rs 558, bouncing back 7% from its early morning low of Rs 523 on the BSE.
10.11 am | 20 Mar 2018 | Business Standard
We have at least a five-year head start in biosimilars compared with other Indian drugmakers, says Mazumdar-Shaw
10.06 am | 19 Mar 2018 | Business Standard
The stock was 7% to Rs 488 on the BSE after the company received EIR from the USFDA for its formulation manufacturing facility in Telangana following ...
9.39 am | 19 Mar 2018 | Business Standard
HEG zoomed 12% to Rs 3,515, also its new high, while Graphite India locked in upper circuit of 5% at Rs 814 on the NSE.
1.33 pm | 16 Mar 2018 | Business Standard
BS ReporterHyderabad, 16 March: Dr Reddy's Laboratories Limited announced today that it has launched Levocetrizine Dihydrochloride tablets, an over-th...
10.06 am | 16 Mar 2018 | Business Standard
TPG Capital, Manipal Health Enterprises likely to make voluntary open offers
11.45 pm | 14 Mar 2018 | Business Standard
Sanofi's European generic business is worth Rs 160 billion; if the deal goes through, it would be the largest outbound acquisition by an Indian drug f...
5.27 pm | 14 Mar 2018 | Press Trust of India
Efavirenz tablet is the generic version of Sustiva tablets of Bristol-Myers Squibb Company
4.20 pm | 13 Mar 2018 | Press Trust of India
The approved Tydemy tablets are generic equivalents of Bayer HealthCare Pharmaceuticals Inc's Safyral tablets, Lupin said
8.55 pm | 12 Mar 2018 | Reuters
Narasimhan, who took over as CEO in February, is emphasising the role of digital technology in helping Novartis come up with winning new therapies
12.38 pm | 12 Mar 2018 | Business Standard
The stock dipped 6% to Rs 528 on the BSE in otherwise firm market.
6.53 pm | 11 Mar 2018 | Press Trust of India
FDA also observed that Aurobindo Pharma employees lack the training required to perform their assigned functions
5.02 pm | 9 Mar 2018 | Business Standard
The company said plant-3 at Bollaram on the city outskirts has recieved these observations upon completion of an inspection
11.14 pm | 8 Mar 2018 | Business Standard
Analysts said given the strong European prospects and as most concerns relating to unit-IV are priced in, downside was limited for the stock
9.48 pm | 8 Mar 2018 | Business Standard
Europe is the third-largest market for Indian drug makers after the US and Africa